- $3.2 Million Verdict for family of MGH patient for doctor's failure to inform patient of all treatment options following abnormal biopsy result.
- $6.8M Judgment for Kidney Cancer Diagnosis Delay - A wrongful death lawsuit against doctor affiliated with Lowell General Hospital
- Jury Awards $6 Million for Woman's Death after Surgery for Hernia - A woman died following hernia surgery at Winchester Hospital
- $1.6M Verdict for Medical Mistake at Dana Farber - Jury decides in favor of patient suffering 3 years of renal failure and dialysis resulting from Dana Farber medication error.
Connecting legal, health and marketing resources with a New England focus — since 2003.
Showing posts with label ma. Show all posts
Showing posts with label ma. Show all posts
9/4/18
Lubin & Meyer Records Four Big Jury Verdicts in First Half of 2018
Boston, Massachusetts based medical malpractice law firm Lubin & Meyer PC has achieved four multi-million dollar jury
verdicts in the first half of 2018. This includes a rare gross negligence verdict. Full trial reports are not yet available on all verdicts, however, the following links contain more information about these four trials.
2/23/15
Noted VC Attorney John Hession Joins Morse, Barnes-Brown & Pendleton
WALTHAM, MA - Veteran Boston-area attorney, John Hession has joined business and IP law firm Morse, Barnes-Brown & Pendleton, PC (MBBP). Hession is a noted VC and attorney serving the technology and life science sectors who served previously at Cooley, LLP, and Testa Hurwitz & Thibeault.
“John’s stellar reputation, his expertise, and his widely admired skills made him an attractive target in the context of our plan for growth,” said MBBP Managing Partner Lisa Warren.
Hession recently authored: Forging Successful Strategic Alliances for Life Sciences Companies.
Morse, Barnes-Brown & Pendleton, PC, focuses exclusively on the core legal services that businesses need to succeed. The law firm assists businesses of all sizes — from start-ups to Fortune 1000 companies — in the areas of corporate law, intellectual property, licensing and strategic alliances, employment and immigration, taxation, and litigation.
“John’s stellar reputation, his expertise, and his widely admired skills made him an attractive target in the context of our plan for growth,” said MBBP Managing Partner Lisa Warren.
Hession recently authored: Forging Successful Strategic Alliances for Life Sciences Companies.
Morse, Barnes-Brown & Pendleton, PC, focuses exclusively on the core legal services that businesses need to succeed. The law firm assists businesses of all sizes — from start-ups to Fortune 1000 companies — in the areas of corporate law, intellectual property, licensing and strategic alliances, employment and immigration, taxation, and litigation.
4/25/11
CoolSculpt by Zeltiq Introduced on Boston's South Shore
Dr. Christine Hamori, a plastic surgeon on Boston's South Shore, is pleased to announce that CoolSculpting from Zeltiq, a new FDA-approved, non-invasive procedure for fat reduction, is now available at her practice in Duxbury, MA on Boston's South Shore. CoolSculpting from Zeltiq uses an innovative method of precisely controlled cooling to help reduce unsightly fat bulges that do not respond to diet and exercise.
The science behind the Coolsculpting procedure is called Cryolipolysis, which was developed by dermatologists at Massachusetts General Hospital in Boston, MA, an affiliate of Harvard Medical School. Their research showed that fat cells are naturally more vulnerable to the effects of cold than other surrounding tissues, and that fat cells can be safely eliminated without harming the overlying skin. This discovery led to the development of the non-invasive Zeltiq procedure.
According to Dr. Hamori, “The new treatment is best suited for relatively fit persons who seek spot reduction for specific trouble areas of fat, but who do not want a surgical invasive procedure."
Dr. Hamori also cautioned that the treatment is not intended for weight reduction, and it is not intended to replace other invasive procedures, like traditional liposuction, for those seeking for more a pronounced result in fat reduction.
For more information, see Dr. Hamori's web page on Zeltiq.
The science behind the Coolsculpting procedure is called Cryolipolysis, which was developed by dermatologists at Massachusetts General Hospital in Boston, MA, an affiliate of Harvard Medical School. Their research showed that fat cells are naturally more vulnerable to the effects of cold than other surrounding tissues, and that fat cells can be safely eliminated without harming the overlying skin. This discovery led to the development of the non-invasive Zeltiq procedure.
According to Dr. Hamori, “The new treatment is best suited for relatively fit persons who seek spot reduction for specific trouble areas of fat, but who do not want a surgical invasive procedure."
Dr. Hamori also cautioned that the treatment is not intended for weight reduction, and it is not intended to replace other invasive procedures, like traditional liposuction, for those seeking for more a pronounced result in fat reduction.
For more information, see Dr. Hamori's web page on Zeltiq.
9/20/06
Big Week for Boston Law Firm Lubin & Meyer
Twice within a week Boston law firm Lubin & Meyer, and Andrew Meyer renowned for its success in winning large verdicts and settlements for victims of medical malpractice and personal injuries, has made headlines. The first was a judgment of $8.4 million to the family of a woman who was sexually abused by a local cantor (See: Cantor to cough up $8.4M for sex abuse. Second for winning what is believed to be (according to the Boston Herald) one of the largest pretrial medical malpractice settlements in New Hampshire — $5.5 million to the family of a boy who was born brain damaged (See: Family awarded $5M after son born impaired. Both articles appeared in the Boston Herald.
For more information, go to Lubin & Meyer's Medical Malpractice Verdicts & Settlements page.
For more information, go to Lubin & Meyer's Medical Malpractice Verdicts & Settlements page.
Subscribe to:
Posts (Atom)